Dyne Therapeutics director Brian S. Posner acquires $40,000 in common shares
DYN•Director Brian S. Posner bought 2,500 Dyne Therapeutics common shares at $16 each, raising his directly held stake to 27,000 shares.
1. Director share purchase
Brian S. Posner bought 2,500 Dyne Therapeutics common shares at $16 per share, a total of $40,000. His directly held stake rose to 27,000 shares following the purchase.
